2020-12-31,Is the Options Market Predicting a Spike in Sesen Bio (SESN) Stock?
2020-12-21,Sesen Bio Submits Completed Biologics License Application to the FDA for Vicineum and Has Requested Priority Review
2020-12-18,Sesen Bio Announces Positive Cost-Effectiveness Profile for Vicineum Based on the Final Evidence Report Issued by the Institute for Clinical and Economic Review (ICER)
2020-12-16,21 Largest Generic Drug Companies
2020-12-09,Sesen Bio (SESN) Surges: Stock Moves 7.8% Higher
2020-12-07,Sesen Bio Announces Commercial Manufacturing and Global Supply Partnership with Qilu Pharmaceutical
2020-12-02,"Should I Buy Sesen Bio, Inc. (SESN)?"
2020-12-01,Sesen Bio Announces Partnership with Hikma Pharmaceuticals for the Commercialization of Vicineum in the Middle East and North Africa
2020-11-16,"Sesen Bio, Inc. (NASDAQ:SESN): When Will It Breakeven?"
2020-11-09,Sesen Bio Reports Third Quarter 2020 Financial Results and Positive Progress Towards Completing the BLA Submission for VicineumTM in December 2020
2020-11-09,"Sesen Bio, Inc. to Host Earnings Call"
2020-11-02,Sesen Bio to Host Conference Call to Review Third Quarter Financial Results and Provide an Update on Positive Progress Towards Demonstration of Analytical Comparability
2020-10-26,Sesen Bio Announces Successful Pre-Submission Meeting with the European Medicines Agency for Vicineum
2020-10-19,Sesen Bio Announces an Exclusive Agreement With Cardinal Health for Third-Party Logistics and Specialty Pharmaceutical Distribution Services for Vicineum
2020-09-15,We Think Sesen Bio (NASDAQ:SESN) Needs To Drive Business Growth Carefully
2020-09-08,Sesen Bio to Provide Business Update at the H. C. Wainwright 22nd Annual Global Investment Conference
2020-09-01,Sesen Bio (SESN) Looks Good: Stock Adds 6.2% in Session
2020-08-10,Sesen Bio Reports Second Quarter 2020 Financial Results and Business Update
2020-08-05,Sesen Bio to Present Regulatory and Business Development Update at the Canaccord Genuity 40th Annual Growth Conference
2020-07-31,Sesen Bio announces an exclusive license agreement with Qilu Pharmaceutical for the development and commercialization of Vicineum in Greater China
2020-07-30,Sesen Bio to Host Conference Call to Provide OUS Business Update
2020-06-12,Edited Transcript of SESN earnings conference call or presentation 11-May-20 12:00pm GMT
2020-06-05,"Should You Avoid Sesen Bio, Inc. (SESN)?"
2020-05-26,Sesen Bio to Present at the Jefferies Virtual Healthcare Conference
2020-05-11,Sesen Bio Reports First Quarter 2020 Financial Results and Meaningful Progress Towards Demonstrating Analytical Comparability
2020-05-07,Sesen Bio Reports Positive Interactions with EMA on Regulatory Pathway for Vicinium®
2020-05-04,Sesen Bio to Host Conference Call to Review First Quarter Financial Results and to Provide Operational Update Highlighting Positive Progress Towards Demonstrating Analytical Comparability
2020-04-07,Edited Transcript of SESN earnings conference call or presentation 16-Mar-20 12:00pm GMT
2020-03-16,"Does Sesen Bio, Inc. (NASDAQ:SESN) Have A High Beta?"
2020-03-16,Sesen Bio Reports Fourth Quarter and Full-Year 2019 Financial Results
2020-02-25,"Dr. Thomas Cannell, President and CEO of Sesen Bio, to Host Conference Call to Provide Business Update Highlighting Regulatory Progress and Commercial Opportunity for Vicinium®"
2020-02-24,Sesen Bio Announces Changes to the Board of Directors as the Company Advances Toward Commercialization of Vicinium®
2020-01-31,Sesen Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-01-14,Did Changing Sentiment Drive Sesen Bio's (NASDAQ:SESN) Share Price Down A Painful 91%?
2019-12-30,Analysts: These 3 Strong Buy Penny Stocks Could Soar in 2020
2019-12-09,Sesen Bio Initiates Rolling Submission of BLA for Vicinium to FDA
2019-12-05,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission"
2019-12-04,Sesen Bio Completes Successful CMC Type B pre-BLA Meeting with FDA
2019-12-02,Edited Transcript of SESN earnings conference call or presentation 12-Nov-19 1:00pm GMT
2019-11-30,"Hedge Funds Are Dumping Sesen Bio, Inc. (SESN)"
2019-11-12,Sesen Bio Reports Third Quarter 2019 Financial Results and Update on Regulatory Activities Related to Vicinium
2019-11-06,"The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings"
2019-11-05,Sesen Bio Announces Successful Type C Meeting with FDA for Vicinium
2019-10-29,Sesen Bio Strengthens Strategic and Financial Optionality
2019-09-23,Will Sesen Bio (NASDAQ:SESN) Spend Its Cash Wisely?
2019-08-27,"The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO"
2019-08-26,Sesen Bio Announces CFO Transition as Company Drives Towards Anticipated Initiation of BLA Submission in 4Q 2019
2019-08-08,"Sesen Bio Reports Positive, Preliminary Data Update from Phase 3 VISTA Trial for High-Risk Non-Muscle Invasive Bladder Cancer"
2019-08-05,Sesen Bio Strengthens Leadership Team
2019-07-31,Sesen Bio to Present at the Canaccord Genuity 39th Annual Growth Conference
2019-07-25,"Introducing Sesen Bio (NASDAQ:SESN), The Stock That Tanked 89%"
2019-07-17,Sesen Bio Announces Retirement of Leslie L. Dan
2019-06-25,Penny Stocks to Buy Using Technical Analysis for June 2019
2019-06-22,Edited Transcript of SESN earnings conference call or presentation 13-May-19 12:00pm GMT
2019-06-21,Implied Volatility Surging for Sesen Bio (SESN) Stock Options
2019-06-19,Sesen Bio Announces Pricing of Public Offering of Common Stock and Warrants
2019-06-19,"The Daily Biotech Pulse: Positive Readouts From Adamas And Ironwood, Sesen Bio To Offer Shares, Stoke Therapeutics Debut"
2019-06-18,Sesen Bio Announces Proposed Public Offering of Common Stock and Warrants
2019-06-10,Sesen Bio Announces Successful Pre-BLA Meeting with FDA for Vicinium®
2019-06-07,"Dr. Thomas Cannell, President and CEO of Sesen Bio, to Host Conference Call to Provide Regulatory Update on Pre-BLA Meeting for Vicinium®"
2019-05-21,"Sesen Bio Announces Acceptance of Analytical Comparability Plan by the U.S. Food and Drug Administration to Support the BLA and Commercialization of Its Lead Asset, Vicinium® for Non-Muscle Invasive Bladder Cancer"
2019-05-20,Options Traders Expect Huge Moves in Sesen Bio (SESN) Stock
2019-05-13,"Sesen Bio Reports First Quarter 2019 Financial Results and Updated, Preliminary Primary and Additional Secondary Endpoint Data from Phase 3 VISTA Trial for High-Risk Non-Muscle Invasive Bladder Cancer"
2019-05-01,"Will the Good News for Vicinium Continue for Sesen Bio, They Will Tell Investors Soon"
2019-04-29,Sesen Bio to Host Conference Call to Review First Quarter 2019 Financial Results and Updated Preliminary Data from Phase 3 VISTA Trial
2019-03-28,Four Healthcare Stocks Getting a Boost on Thursday
2019-03-27,Positive Results and New Technology Give Rise to Antibody Dominance
2019-03-09,Edited Transcript of SESN earnings conference call or presentation 4-Mar-19 1:00pm GMT
2019-03-07,"What Kind Of Shareholder Owns Most Sesen Bio, Inc. (NASDAQ:SESN) Stock?"
2019-03-04,Sesen Bio Reports Fourth Quarter and Full-Year 2018 Financial Results and Additional Preliminary Data from Phase 3 VISTA Trial
2019-02-25,Sesen Bio to Host Conference Call to Review Fourth Quarter and Full-Year 2018 Financial Results and Additional Preliminary Data from Phase 3 VISTA Trial
2019-01-22,Health Stocks Benefitting the Most from Rally
2019-01-18,"Sesen Bio, Inc. (NASDAQ:SESN): A Fundamentally Attractive Investment"
2019-01-03,Sesen Bio Announces Positive Preliminary 12-Month Data from Registration Phase 3 VISTA Trial of Vicinium for Non-Muscle Invasive Bladder Cancer
2018-12-27,4 Healthcare Stocks That Could Test December Highs
2018-12-27,Sesen Bio to Host Conference Call to Review Updated VISTA Trial Data in Non-Muscle Invasive Bladder Cancer
2018-12-03,"Sesen Bio Appoints Drug Development Expert, Dennis Kim, M.D., MPH, as Chief Medical Officer"
2018-11-08,3 Health Care Stocks Seeing Heightened Activity After Midterms
2018-11-08,Sesen Bio Reports Third Quarter 2018 Financial Results and Planned VISTA Trial Readouts
2018-10-15,Implied Volatility Surging for Sesen Bio (SESN) Stock Options
2018-09-27,Do Institutions Own Shares In Sesen Bio Inc (NASDAQ:SESN)?
2018-09-20,Sesen Bio to Present Three-month VISTA Trial Data at Global Congress on Bladder Cancer 2018
2018-09-05,Here's Why Momentum Investors Will Love Sesen Bio (SESN)
2018-09-05,Sesen Bio (SESN) Continue to Surge Higher?
2018-08-31,3 Cancer Treatment Stocks that Moved Higher in August
2018-08-14,Sesen Bio Reports Second Quarter 2018 Financial Results and Pipeline Updates
2018-08-09,Sesen Bio Announces Vicinium Granted Fast Track Designation by FDA for Treatment of Non-Muscle Invasive Bladder Cancer
2018-08-07,Sesen Bio Announces CEO and Board Transitions as Company Prepares for 12-Month VISTA Trial Data and Regulatory Submission in 2019
2018-08-02,Sesen Bio to Present at the Canaccord Genuity 38th Annual Growth Conference
2018-07-27,Free Pre-Market Technical Pulse on Sesen Bio and Three More Biotech Stocks
2018-06-20,Stock Performance Review on Sesen Bio and Three Other Biotech
2018-06-05,Sesen Bio (SESN) Sees Hammer Chart Pattern: Time to Buy?
2018-06-04,Sesen Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares of Common Stock
2018-05-30,Sesen Bio Announces Pricing of Public Offering of Common Stock
2018-05-30,Sesen Bio Announces Proposed Public Offering of Common Stock
2018-05-29,Sesen Bio to Present at the Jefferies 2018 Global Healthcare Conference
2018-05-21,Phase 3 Registration Trial for Non-Muscle Invasive Bladder Cancer Achieves 42% Complete Response Rate at Three Months in Carcinoma in Situ Patients
2018-05-21,NasdaqGM Healthcare Industry: A Dive Into Sesen Bio Inc (NASDAQ:SESN)
